List of insiders holdings for Pandion Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Merck & Co. Inc. MERCK SHARP & DOHME CORP. 10% Owner | 2021-03-04 06:06:59 | 11,776,706 0 | 11,776,706 | Form 13D |
Polaris Partners GP VIII L.L.C. Polaris Entrepreneurs' Fund VIII L.P. Polaris Partners VIII L.P. 10% Owner | 2021-02-12 17:16:00 | 3,201,422 0 | 3,201,422 | Form 13G |
Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 2020-07-31 16:26:52 | 3,176,507 0 | 3,176,507 | Form 13G |
ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner | 2021-02-16 07:02:33 | 3,086,084 0 | 3,086,084 | Form 13G |
Access Industries Holdings LLC AI Pan LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 2021-02-16 06:20:31 | 2,827,883 0 | 2,827,883 | Form 13G |
Boxer Capital LLC Boxer Asset Management Inc. Braslyn Ltd. LEWIS JOSEPH Davis Aaron I. MVA Investors LLC 10% Owner | 2020-07-29 21:05:49 | 2,107,513 0 | 2,107,513 | Form 13D |
JDRF T1D Fund LLC 10% Owner | 2020-07-21 19:45:19 | 426,333 0 | 426,333 | Form 4 |
Mutz Mitchell Director 10% Owner | 2020-07-23 16:49:25 | 0 10,000 | 10,000 | Form 4 |
Viney Joanne L. See Remarks | 2021-04-01 19:59:21 | 0 0 | 0 | Form 4 |
Goyal Vikas See Remarks | 2021-04-01 19:58:39 | 0 0 | 0 | Form 4 |
ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC 10% Owner | 2022-02-11 16:39:00 | 0 0 | 0 | Form 13G |
Crane Alan L Director 10% Owner | 2021-04-01 19:57:32 | 0 0 | 0 | Form 4 |
Freedman Edward D. Chief Operating Officer | 2021-04-01 19:55:34 | 0 0 | 0 | Form 4 |
BELOFF GREGG See Remarks | 2021-04-01 19:53:42 | 0 0 | 0 | Form 4 |
Kakkar Rahul Chief Executive Officer | 2021-04-01 19:50:04 | 0 0 | 0 | Form 4 |
Fuglesang Christopher Director 10% Owner | 2021-04-01 19:49:41 | 0 0 | 0 | Form 4 |
Becker Daniel J. Director | 2021-04-01 19:49:34 | 0 0 | 0 | Form 4 |
Sundy John Chief Medical Officer | 2021-04-01 19:46:47 | 0 0 | 0 | Form 4 |
Stagliano Nancy Director | 2021-04-01 19:46:19 | 0 0 | 0 | Form 4 |
Dorton Katina Director | 2021-04-01 19:45:30 | 0 0 | 0 | Form 4 |
Frail Donald Director | 2021-04-01 19:45:13 | 0 0 | 0 | Form 4 |
Carroll Jill Director 10% Owner | 2021-04-01 19:43:31 | 0 0 | 0 | Form 4 |
Carlo Rizzuto Director | 2021-04-01 19:38:56 | 0 0 | 0 | Form 4 |
Larson Eric D Vice President, Finance | 2021-04-01 19:37:59 | 0 0 | 0 | Form 4 |
RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 2021-05-17 16:35:46 | 0 0 | 0 | Form 13G |
GLAXOSMITHKLINE PLC Director 10% Owner | 2021-04-08 17:24:29 | 0 0 | 0 | Form 13D |